Lung cancer gene study halted early
NCT ID NCT01946100
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at the genetics of people with multiple lung tumors (multifocal lung adenocarcinoma). Researchers collected tissue and blood samples from 100 participants during surgery to analyze their DNA. The goal was to see if genetic information could help guide treatment and improve survival. However, the study was terminated early, so the full results are not available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better understand the genetics of multiple lung tumors and guide more personalized treatment decisions.
- What could go wrong
- The study was terminated early, so results may be limited. It was an observational tissue collection, not a treatment trial, so no direct benefit to participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can immunotherapy be safely used in early lung cancer? a Real-World study investigates
- Light-Based blood test may spot lung cancer early
- Get up and eat: a new approach to speed lung surgery recovery?
- Repositioning arms during lung surgery may cut Post-Op shoulder pain
- Can a Heat-and-Freeze treatment plus a vaccine outsmart pancreatic cancer?